WIBR3_PINK1_Q129X_E2-2
WIBRe001-A-12
General
Cell Line |
|
| hPSCreg name | WIBRe001-A-12 |
| Cite as: | WIBRe001-A-12 (RRID:CVCL_C7VM) |
| Alternative name(s) |
WIBR3_PINK1_Q129X_E2-2
|
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines | No similar lines found. |
| Last update | 13th December 2024 |
| Notes | Internal experimental control(s) were generated undergoing the same experimental procedure and are registered as WIBRe001-A-35 and WIBRe001-A-36. |
| User feedback | |
Provider |
|
| Generator | University of California, Berkeley (CAL) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA114332364 |
| Cellosaurus | CVCL_C7VM |
| Wikidata | Q123033879 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
| Ethnicity | unknown |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
| Family history | no |
| Is the medical history available upon request? | no |
| Is clinical information available? | no |
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA104129930 |
Ethics
Also have a look at the ethics information for the parental line
WIBRe001-A
.
hESC Derivation
|
The source cell information can be found in the parental cell line
WIBRe001-A.
|
Culture Conditions
| Medium |
Other medium:
Base medium: DMEM/F12
Main protein source: Fetal bovine serum Serum concentration: 15 % |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|||||
| POU5F1 (OCT-4) |
Yes |
|||||
| SSEA-4 |
Yes |
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.